Stay updated with the latest insights and trends in the IVD market.
A new Washington Post analysis underscores a critical reality of the 2025–2026 respiratory season: flu and COVID‑19 are evolving differently, but their symptoms are increasingly overlapping—making d...
Published on 2026-03-04 12:56:31 by giendi
Read MoreA new Washington Post analysis underscores a critical reality of the 2025–2026 respiratory season: flu and COVID‑19 are evolving differently, but their symptoms are increasingly overlapping—making d...
Published on 2026-03-04 12:56:31 by giendi
Read MoreAccording to recent analyses, **billions of dollars in fraudulent Medicare payments** have flowed through non‑MolDX jurisdictions, particularly in states where pop‑up labs were able to bill tens of mi...
Published on 2026-03-03 14:35:27 by giendi
Read MoreHeart Disease in Young Women Is Projected to Surge by 2050 — A Wake‑Up Call for Cardiovascular Prevention New projections highlighted by Scientific American show a dramatic shift in cardiovascular ...
Published on 2026-02-26 21:14:25 by giendi
Read MoreLEX Diagnostics just secured FDA 510(k) clearance and CLIA‑waived status for its ultra‑fast VELO PCR system—another major milestone in the evolution of point‑of‑care molecular testing. The VELO...
Published on 2026-02-20 14:22:58 by giendi
Read More# **Summary: Annual Report to the Nation on the Status of Cancer (2025)** The 2025 report shows a **continued, steady decline in U.S. cancer death rates** for men, women, and children from **2001 t...
Published on 2026-02-13 18:41:13 by giendi
Read MoreMedicare’s expanding coverage of Personalis’ NeXT Personal® MRD assay is another major signal that ultra‑sensitive, tumor‑informed ctDNA testing is becoming a core component of cancer surveillance. ...
Published on 2026-02-12 20:24:39 by giendi
Read MoreEarly PSA screening is one of the clearest examples of how a simple blood test can change outcomes. Prostate cancer affects roughly 1 in 8 people with a prostate, yet when it’s caught early, the five‑...
Published on 2026-02-11 00:04:00 by giendi
Read More**OraSure Technologies has submitted two FDA 510(k) applications for a rapid molecular self-test for chlamydia and gonorrhea (CT/NG) and an at-home urine collection device (Colli-Pee), signaling a maj...
Published on 2026-01-29 12:43:30 by giendi
Read More## **🔍 Diasorin & Thermo Fisher Sign Exclusive U.S. Distribution Deal — A Major Move in Rapid Molecular POC Expansion** Diasorin has entered an **exclusive U.S. hospital‑channel distribution agreem...
Published on 2026-01-26 18:42:06 by giendi
Read MoreA new article just accepted for publication in the Journal of the American College of Cardiology (https://www.jacc.org/doi/10.1016/j.jacc.2025.09.1613) reports a powerful message for cardiovascular pr...
Published on 2026-01-26 11:53:01 by giendi
Read MoreThe 2026 J.P. Morgan Healthcare Conference made one thing clear: In‑vitro diagnostics is entering a new era defined by AI‑enabled performance, precision partnerships, and disciplined execution. Acros...
Published on 2026-01-24 15:41:15 by giendi
Read MoreDiasorin just secured FDA 510(k) clearance and CLIA waiver for its first assay on the Liaison NES, a next‑generation molecular point‑of‑care platform capable of delivering PCR‑quality results in 15 mi...
Published on 2026-01-24 15:39:12 by giendi
Read More**It’s not too late for flu vaccination — and this season the "Super Flu is going around.** Medscape recently interviewed **Lisa Grohskopf, MD, MPH**, from the CDC’s Influenza Division, who outline...
Published on 2026-01-21 17:31:37 by Admin
Read More